Menu UF Health Home Menu
 

Leukemia/Lymphoma

UF Pediatric Hematology / OncologyUF Pediatric Hematology / OncologyUF Pediatric Hematology / Oncology

Leukemia is the most prevalent childhood cancer, and represents about 1/3 of all cancers in children. Although pediatric leukemia is highly curable, nearly 20 percent of children with leukemia will relapse. Furthermore, treatments are difficult, and can lead to stroke, diabetes, and severe arthritis leading to joint replacements. Our research is focused on finding better cures for our young patients with this disease. Specific research initiatives include focus on leukemia stem cells and the development of drugs that can be taken by mouth and destroy cancer cells but leave normal tissue alone.

Key Players

Researchers

  • William Slayton – Targeted therapy for high risk childhood Leukemia and clinical trials for Philadelphia Chromosome Positive Leukemia
  • Lamis Elderjou – Clinical trials for Philadelphia Chromosome Positive Leukemia
  • Zhongbo Hu – Targets for Philadelphia Chromosome Positive Leukemia
  • Xiao Miao Li – Stem Cells and the Microenvironment
  • David Ostrov – Drug Design and X-ray Crystallography